DocuSign (DOCU) is in focus after releasing a joint report with Deloitte on AI driven agreement workflows, highlighting that customers using agentic, end to end platforms are seeing materially higher returns on their agreement related investments.

Despite the AI focused report with Deloitte, sentiment around DocuSign’s recent performance has been cautious, with a 1 day share price return of 0.69% decline, a 7 day share price return of 6.64% gain, a year to date share price return of 29.47% decline, and a 1 year total shareholder return of 39.35% decline pointing to fading momentum overall.

If AI driven agreement workflows interest you, it could be worth seeing how other companies are positioned by scanning a focused list of 34 AI small caps

With DocuSign trading at US$45.74 and sitting at a 31.5% discount to the average analyst price target, and with an implied 65.7% gap to some intrinsic value estimates, you have to ask: is there real upside here, or is the market already pricing in all the AI fueled growth?

Most Popular Narrative: 24% Undervalued

The most followed narrative puts DocuSign’s fair value at $60.16, above the last close of $45.74. That gap is explained by future growth and profitability assumptions rather than recent share price weakness.

Rollout and ramp-up of the IAM platform, with AI-native features and deep enterprise system integrations, is unlocking significant upsell opportunities as customers migrate from core eSignature to broader agreement management. This is driving improved ARPU and supporting double-digit future topline growth.

Want to see what sits behind that optimism? The narrative leans on recurring revenue, margin uplift and a richer product mix to justify that higher fair value.

Result: Fair Value of $60.16 (UNDERVALUED)

However, slower guidance for revenue and billings growth, along with rising competition in e-signature and AI agreement tools, could both challenge that upbeat fair value story.

Next Steps

With sentiment clearly mixed, do you want to rely on others or quickly evaluate the trade-off between concerns and optimism yourself using 3 key rewards and 1 important warning sign?

Looking for more investment ideas?

Do not stop your research at a single stock; widen your view with a few focused stock lists so you can spot opportunities before they feel obvious.

• Target income potential by reviewing companies that feature reliable payouts with 11 dividend fortresses.
• Hunt for quality at a reasonable entry point by scanning 59 high quality undervalued stocks.
• Prioritise resilience by focusing on companies that pass strong financial health checks with the solid balance sheet and fundamentals stocks screener (42 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.